Skip to content

TAOX

TAO Synergies Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.89
−4.07%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-0.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 19, 2026Silverman Joshua · director, officer: Executive ChairmanA-Award200,000$4.80
May 19, 2026Ephron Robert · directorA-Award10,000$4.80
May 19, 2026WEINSTEIN ROBERT · officer: Chief Financial OfficerA-Award30,000$4.80
May 19, 2026Singer William S. · directorA-Award35,000$4.80
May 19, 2026Bernstein Bruce · directorA-Award55,000$4.80
Apr 8, 2026Ephron Robert · directorA-Award800$5.52
Apr 8, 2026Bernstein Bruce · directorA-Award800$5.52
Apr 8, 2026Singer William S. · directorA-Award800$5.52
Feb 5, 2026TUCHMAN ALAN J · director, officer: Chief Medical OfficerA-Award2,000$10
Oct 17, 2025Silverman Joshua · director, officer: Executive ChairmanA-Award36,000$10
Oct 17, 2025SCHECHTER JONATHAN · directorA-Award10,000$10
Oct 17, 2025Ephron Robert · directorA-Award7,500$0.00
Oct 17, 2025Ephron Robert · directorF-InKind3,000$7.23
Oct 17, 2025Bernstein Bruce · directorA-Award25,000$0.00
Oct 17, 2025Bernstein Bruce · directorF-InKind10,000$7.23
Oct 17, 2025Bernstein Bruce · directorA-Award12,000$10
Oct 17, 2025Silverman Joshua · director, officer: Executive ChairmanF-InKind40,000$7.23
Oct 17, 2025Silverman Joshua · director, officer: Executive ChairmanA-Award100,000$0.00
Oct 17, 2025Singer William S. · directorA-Award7,000$10
Oct 17, 2025Singer William S. · directorF-InKind6,000$7.23
Oct 17, 2025Singer William S. · directorA-Award15,000$0.00
Oct 17, 2025WEINSTEIN ROBERT · officer: Chief Financial OfficerA-Award7,000$10
Oct 17, 2025WEINSTEIN ROBERT · officer: Chief Financial OfficerF-InKind4,000$7.23
Oct 17, 2025WEINSTEIN ROBERT · officer: Chief Financial OfficerA-Award10,000$0.00
Jul 2, 2025Bernstein Bruce · directorA-Award24,657$0.00
Jul 2, 2025Bernstein Bruce · directorF-InKind9,863$7.85
Jul 2, 2025TUCHMAN ALAN J · director, officer: Chief Medical OfficerA-Award4,315$0.00
Jul 2, 2025TUCHMAN ALAN J · director, officer: Chief Medical OfficerF-InKind1,726$7.85
Jul 2, 2025Singer William S. · directorA-Award15,410$0.00
Jul 2, 2025Singer William S. · directorF-InKind6,164$7.85
Institutional positioning

13F filings over the trailing two quarters

New 14Increased 14Reduced 9Sold out 2
FilerActionSharesFiled
VANGUARD CAPITAL MANAGEMENT LLCIncreased118,471Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased101,800May 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased88,644May 15, 2026
CITADEL ADVISORS LLCNew Position83,172Sep 2, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced79,374Aug 12, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position79,369May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced78,817Aug 13, 2026
Summit Financial, LLCIncreased57,760Aug 12, 2026
JANE STREET GROUP, LLCNew Position54,854Aug 14, 2026
BlackRock, Inc.Increased45,898Aug 7, 2026
VANGUARD FIDUCIARY TRUST CONew Position45,432May 8, 2026
SUMMIT FINANCIAL, LLCIncreased43,275May 15, 2026
HRT FINANCIAL LPNew Position40,072Aug 14, 2026
UBS Group AGIncreased32,779Aug 13, 2026
VANGUARD FIDUCIARY TRUST COReduced31,889Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 19, 2026